Cargando…
Gut microbiota composition in COVID-19 hospitalized patients with mild or severe symptoms
BACKGROUND AND AIM: COVID-19, the infectious disease caused by SARS-CoV-2 virus that has been causing a severe pandemic worldwide for more than 2 years, is characterized by a high heterogeneity of clinical presentations and evolution and, particularly, by a varying severity of respiratory involvemen...
Autores principales: | Mazzarelli, Antonio, Giancola, Maria Letizia, Fontana, Andrea, Piselli, Pierluca, Binda, Elena, Trivieri, Nadia, Mencarelli, Gandino, Marchioni, Luisa, Vulcano, Antonella, De Giuli, Chiara, Panebianco, Concetta, Villani, Annacandida, Copetti, Massimiliano, Perri, Francesco, Fontana, Carla, Nicastri, Emanuele, Pazienza, Valerio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9763305/ https://www.ncbi.nlm.nih.gov/pubmed/36560946 http://dx.doi.org/10.3389/fmicb.2022.1049215 |
Ejemplares similares
-
High Levels of Prebiotic Resistant Starch in Diet Modulate a Specific Pattern of miRNAs Expression Profile Associated to a Better Overall Survival in Pancreatic Cancer
por: Trivieri, Nadia, et al.
Publicado: (2020) -
Investigation of Nasal/Oropharyngeal Microbial Community of COVID-19 Patients by 16S rDNA Sequencing
por: Rueca, Martina, et al.
Publicado: (2021) -
Improving Gemcitabine Sensitivity in Pancreatic Cancer Cells by Restoring miRNA-217 Levels
por: Panebianco, Concetta, et al.
Publicado: (2021) -
High Levels of Prebiotic Resistant Starch in Diet Modulate Gene Expression and Metabolomic Profile in Pancreatic Cancer Xenograft Mice
por: Panebianco, Concetta, et al.
Publicado: (2019) -
Targeting Gut Microbiota in Cancer Cachexia: Towards New Treatment Options
por: Panebianco, Concetta, et al.
Publicado: (2023)